An exploratory study of new features of test foods. - A placebo controlled, randomized, double blind, cross-over study - - An exploratory study of new features of test foods.

KSO Corporation0 sites40 target enrollmentFebruary 6, 2021

ConditionsHealthy adult

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy adult
Sponsor: KSO Corporation
Enrollment: 40
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

February 6, 2021

End Date

March 7, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

Male

Investigators

Sponsor

KSO Corporation

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\)Subjects who has determined to be inappropriate as a subject by the investigator by a blood test performed on a screening test. (2\)Subjects who have chronic disease and regularly use drugs and/or medicines and have serious complications. (3\)Subjects who regularly use medicines related to intestinal regulation. (4\)Subjects who has food allergy. (5\)Subjects who take health foods (including Food for Specified Health Uses or Foods with Function Claims) and/or supplements on a daily basis. (6\)Subjects who have digestive disorders that affect digestion and absorption and/or have a history of digestive surgery, and/or have disorders of the digestive tract such as stricture. (7\)Subjects who couldn't take the prescribed meal to be carried out within the prescribed time in the screening test. (8\)Subjects who had problems with gastrointestinal symptoms such as diarrhea and abdominal pain after taking the prescribed meal in the screening test. (9\)Subjects who did not defecate pigmented stool within 26 hours after taking the prescribed meal and pigment capsule in the screening test. (10\)Subjects who may do a lot of sweating work or exercise during the test period. (11\)Subjects who smoke. (12\)Subjects who usually have a tendency to develop diarrhea or constipation. (13\)Subjects who has a medical history or current medical history of drug dependence and/or alcohol dependence. (14\)Subjects who are participating in other studies that using foods, pharmaceuticals, and cosmetics now, or who have been participated or are willing to participate in other studies within a month from the date of informed consent. (15\)Subjects who are judged as unsuitable for the study by the investigator for the other reasons.